| Breakdown | TTM | Mar 2024 | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.70M | 72.50M | -53.70M | 66.50M | 40.97M | 22.81M |
| Gross Profit | 66.40M | 72.50M | -53.70M | 56.90M | 33.76M | 18.77M |
| EBITDA | 1.70M | 70.10M | 0.00 | -7.80M | 0.00 | 0.00 |
| Net Income | 36.70M | 70.10M | -56.30M | -18.60M | 79.80M | 32.41M |
Balance Sheet | ||||||
| Total Assets | 953.30M | 985.40M | 984.50M | 1.13B | 1.07B | 695.03M |
| Cash, Cash Equivalents and Short-Term Investments | 1.10M | 900.00K | 500.00K | 300.00K | 146.06M | 122.06M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 2.40M | 1.80M | 2.60M | 3.30M | 1.54M | 1.23M |
| Stockholders Equity | 950.90M | 983.60M | 981.90M | 1.13B | 1.07B | 693.80M |
Cash Flow | ||||||
| Free Cash Flow | 52.20M | 58.00M | 53.10M | 331.10M | 340.21M | 322.93M |
| Operating Cash Flow | 52.20M | 58.00M | 53.10M | 57.20M | 32.31M | 19.47M |
| Investing Cash Flow | 15.20M | 10.80M | 34.30M | -273.90M | -307.86M | -303.46M |
| Financing Cash Flow | -68.70M | -68.40M | -87.20M | 70.90M | 299.56M | 337.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £59.73M | 4.85 | 10.22% | 8.23% | 8.48% | 207.85% | |
70 Outperform | ― | 3.78 | 5519.21% | 3.92% | 21.04% | -21.14% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ― | -14.43 | -0.72% | 10.37% | 19.76% | -122.32% | |
61 Neutral | ― | 90.35 | 3.79% | 12.26% | 3.36% | ― | |
59 Neutral | ― | ― | ― | ― | ― | ― | |
44 Neutral | ― | -1.48 | -47.36% | 3.45% | ― | ― |